BRISTOL-MYERS SQUIBB COMPANY Equity Securities, FV-NI, Realized Gain (Loss)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Equity Securities, FV-NI, Realized Gain (Loss) of $1.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-06-30 was $1.00M.
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-03-31 was $6.00M.
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-12-31 was $9.00M.
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for fiscal 2025 was $4.00M.
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for fiscal 2024 was -$32.00M, a 1166.67% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for fiscal 2023 was $3.00M, a 82.35% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY equity securities, fv-ni, realized gain (loss) for fiscal 2022 was $17.00M, a 95.24% decline from fiscal 2021.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-07-30 | $7.00M 10-Q · filed 2026-07-30 | $16.00M derived: sum of 3 quarters · filed 2026-07-30 | $16.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $6.00M 10-Q · filed 2026-04-30 | $15.00M derived: sum of 2 quarters · filed 2026-04-30 | $15.00M derived: sum of 3 quarters · filed 2026-04-30 | $13.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $9.00M derived: sum of 2 quarters · filed 2026-02-11 | $7.00M derived: sum of 3 quarters · filed 2026-07-30 | $4.00M 10-K · filed 2026-02-11 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 | -$2.00M derived: sum of 2 quarters · filed 2026-07-30 | -$5.00M 10-Q · filed 2025-10-30 | -$40.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | -$2.00M 10-Q · filed 2026-07-30 | -$5.00M 10-Q · filed 2026-07-30 | -$40.00M derived: sum of 3 quarters · filed 2026-07-30 | -$37.00M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | -$4.00M 10-Q · filed 2026-04-30 | -$38.00M derived: sum of 2 quarters · filed 2026-04-30 | -$35.00M derived: sum of 3 quarters · filed 2026-04-30 | -$35.00M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | -$34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$31.00M derived: sum of 2 quarters · filed 2026-02-11 | -$31.00M derived: sum of 3 quarters · filed 2026-02-11 | -$32.00M 10-K · filed 2026-02-11 | |
| 2024-09-30 | $3.00M 10-Q · filed 2025-10-30 | $3.00M derived: sum of 2 quarters · filed 2025-10-30 | $2.00M 10-Q · filed 2025-10-30 | $6.00M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-31 | -$1.00M 10-Q · filed 2025-07-31 | $3.00M derived: sum of 3 quarters · filed 2026-02-11 | $89.00M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-03-31 | -$2.00M 10-Q · filed 2025-04-24 | $3.00M derived: sum of 2 quarters · filed 2026-02-11 | $89.00M derived: sum of 3 quarters · filed 2026-02-11 | $100.00M derived: sum of 4 quarters · filed 2026-02-11 | |
| 2023-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $91.00M derived: sum of 2 quarters · filed 2026-02-11 | $102.00M derived: sum of 3 quarters · filed 2026-02-11 | $3.00M 10-K · filed 2026-02-11 | |
| 2023-09-30 | $86.00M 10-Q · filed 2024-10-31 | $97.00M derived: sum of 2 quarters · filed 2024-10-31 | -$2.00M 10-Q · filed 2024-10-31 | $98.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | $11.00M 10-Q · filed 2024-07-26 | $12.00M 10-Q · filed 2024-07-26 | $12.00M derived: sum of 3 quarters · filed 2025-02-12 | $13.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | $1.00M 10-Q · filed 2024-04-25 | $1.00M derived: sum of 2 quarters · filed 2025-02-12 | $2.00M derived: sum of 3 quarters · filed 2025-02-12 | $18.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.00M derived: sum of 2 quarters · filed 2025-02-12 | $17.00M derived: sum of 3 quarters · filed 2025-02-12 | $17.00M 10-K · filed 2025-02-12 | |
| 2022-09-30 | $1.00M 10-Q · filed 2023-10-26 | $17.00M derived: sum of 2 quarters · filed 2023-10-26 | $17.00M 10-Q · filed 2023-10-26 | $379.00M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-06-30 | $16.00M 10-Q · filed 2023-07-27 | $16.00M 10-Q · filed 2023-07-27 | $378.00M derived: sum of 3 quarters · filed 2024-02-13 | $375.00M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-04-27 | $362.00M derived: sum of 2 quarters · filed 2024-02-13 | $359.00M derived: sum of 3 quarters · filed 2024-02-13 | $360.00M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2021-12-31 | $362.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $359.00M derived: sum of 2 quarters · filed 2024-02-13 | $360.00M derived: sum of 3 quarters · filed 2024-02-13 | $357.00M 10-K · filed 2024-02-13 | |
| 2021-09-30 | -$3.00M 10-Q · filed 2022-10-26 | -$2.00M derived: sum of 2 quarters · filed 2022-10-26 | -$5.00M 10-Q · filed 2022-10-26 | $91.00M 10-Q · filed 2021-10-27 | -$17.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $1.00M 10-Q · filed 2022-07-27 | -$2.00M 10-Q · filed 2022-07-27 | -$14.00M derived: sum of 3 quarters · filed 2023-02-14 | -$14.00M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-03-31 | -$3.00M 10-Q · filed 2022-04-29 | -$15.00M derived: sum of 2 quarters · filed 2023-02-14 | -$15.00M derived: sum of 3 quarters · filed 2023-02-14 | -$15.00M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2020-12-31 | -$12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$12.00M derived: sum of 2 quarters · filed 2023-02-14 | -$12.00M derived: sum of 3 quarters · filed 2023-02-14 | -$12.00M 10-K · filed 2023-02-14 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-10-27 | $0.00 derived: sum of 2 quarters · filed 2021-10-27 | $0.00 10-Q · filed 2021-10-27 | $0.00 derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-28 | $0.00 10-Q · filed 2021-07-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-09 | $0.00 derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2022-02-09 | $0.00 derived: sum of 3 quarters · filed 2022-02-09 | $0.00 derived: sum of 4 quarters · filed 2022-02-09 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $0.00 derived: sum of 2 quarters · filed 2022-02-09 | $0.00 derived: sum of 3 quarters · filed 2022-02-09 | $14.00M 10-K · filed 2022-02-09 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $14.00M 10-Q · filed 2020-11-05 | $21.00M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $14.00M 10-Q · filed 2020-08-06 | $21.00M derived: sum of 3 quarters · filed 2021-02-10 | $21.00M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-03-31 | $14.00M 10-Q · filed 2020-05-07 | $21.00M derived: sum of 2 quarters · filed 2021-02-10 | $21.00M derived: sum of 3 quarters · filed 2021-02-10 | $21.00M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2018-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $7.00M derived: sum of 2 quarters · filed 2021-02-10 | $7.00M derived: sum of 3 quarters · filed 2021-02-10 | $7.00M 10-K · filed 2021-02-10 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-25 | $0.00 10-Q · filed 2019-07-25 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |